Leaky Brain: Why Your Waistline Predicts It Better Than Amyloid

A leaky brain is a blood-brain barrier that lets contrast dye seep out of its vessels. Scans show it opening first in the hippocampus, where memories are filed. What pries it open looks like metabolic disease. The leak tracked diabetes, strained vessel linings and waist size, not amyloid.

For decades the blood-brain barrier was drawn as a brick wall with the brain safe behind it. I drew it that way for residents. Then researchers put living people in a scanner. They tracked contrast dye seeping out of brain blood vessels, and found the wall leaking in one place first.

That place is the hippocampus, where memories are filed. What opens it looks more like metabolic disease than amyloid. That is the real story behind a leaky brain. The video above comes from Chapter 12 of The Angry Gut, co-written by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. This page is about measurement and the numbers you can move.

Where does the blood-brain barrier leak first?

Using dynamic contrast MRI, one team compared older adults with normal thinking against young controls. Leakage was higher by 41% in the hippocampus, 107% in its CA1 subfield and 48% in the dentate gyrus. In mild cognitive impairment, those same regions climbed again against people of the same age, by 24%, 53% and 27% (Montagne et al., 2015).

How do we know the scanner is not just picking up noise? The same series checked people with multiple sclerosis, and their map was the reverse. Leakage rose in total white matter, corpus callosum and internal capsule by 32%, 26% and 23%, with no change in the hippocampus. A method that draws a different map in a different disease is measuring something local and real.

Genetics sharpens the picture. The team scanned 245 people and measured spinal fluid in 350. APOE4 carriers with normal thinking already showed breakdown in the hippocampus and the nearby parahippocampal gyrus. Amyloid and tau tracer uptake did not differ. Injury to pericytes, the cells that keep the barrier’s seams closed, predicted later decline in carriers and in no one else (Montagne et al., 2020).

Does a leaky brain start before brain inflammation?

Here is the result almost nobody prints. In the people whose hippocampus was leaking, spinal fluid was checked for the usual inflammatory suspects. Interleukin-6, tumor necrosis factor-alpha, interferon-gamma, adhesion molecules, tau and amyloid: none had moved. Two things did. A marker of pericyte injury was 115% higher in mild impairment than in same-age controls. And the older albumin ratio was up 30% (Montagne et al., 2015).

A follow-up in 161 people with spinal fluid found no differences between impaired and unimpaired people across 20 inflammation and degeneration markers. The barrier measure still predicted impairment after accounting for amyloid and tau (Nation et al., 2019). That cohort left out vascular dementia. And these papers come from one group with overlapping cohorts. It is a growing record, not independent replication.

The order still matters. If the door opens before the inflammation arrives, an anti-inflammatory is late by design. The earlier lever is whatever is prying the door open.

What causes a leaky brain? Insulin, blood vessels and body shape

The cheaper, older test is the ratio of albumin in spinal fluid to albumin in blood. In 1,015 people it was unchanged in early and pre-symptom Alzheimer’s disease. It did not follow amyloid imaging or APOE genotype. It followed diabetes. It also rose with proteins that a strained blood-vessel lining sheds, including vascular endothelial growth factor and two adhesion molecules (Janelidze et al., 2017). In healthy older people from that series, high body mass index and waist-hip ratio predicted a leaking barrier twenty years later.

A second cohort of 1,861 people with dementia found the ratio raised across Lewy body, late-onset Alzheimer’s, vascular and mixed dementia. Within those groups it tracked neurofilament light, a marker of damaged nerve fibers. It did not track Alzheimer’s markers (Skillbäck et al., 2017). A leak that follows nerve fiber damage and ignores amyloid reads as a blood-vessel problem wearing a neurology label.

Diabetes shows the timing. In type 2 diabetes, white matter leakage was already raised before any small vessel disease showed on a standard scan. Recent blood sugar control explained none of it (Chen et al., 2022). A decent A1C this quarter did not protect the barrier. The study is small, 25 patients with diabetes against 12 without.

So the model has two biological drivers. One is years of high insulin and glucose load. The other is a blood-vessel lining under metabolic strain. The third driver is not biological at all. It is a food supply built and subsidized to grow waistlines. That moves this fight out of the memory clinic and into the kitchen.

Researchers studied tissue after death from 12 people with CADASIL, a genetic small vessel disease, and 10 controls. Leakage was not a steady feature of white matter lesions (Rajani et al., 2019). Not every bright spot on an MRI report means an open barrier.

Bacteria in the brain? What contamination controls found

If the barrier opens, something crosses. The trendy answer is a brain microbiome. One lab re-ran brain tissue with proper controls. 54.8% of the apparent bacterial DNA had come in with the lab chemicals. Another 34.2% was the patient’s own DNA misread by software (Bedarf et al., 2021). In blood, 84% of 9,770 healthy people had no detectable species at all (Tan et al., 2023).

The honest verdict is traffic, not a colony. Bacterial products and immune signals reach the second brain. Traffic matters when the door stays open for years.

Which tests help, and which ones mislead

• Two barrier measures, two answers. Contrast MRI caught hippocampal leakage early. The bulk albumin ratio did not budge in early Alzheimer’s.
• Microbleeds on an ordinary scan. The diabetes study tested 4,500 candidate criteria. Only six separated leakage, and the one that worked was microbleeds (Chen et al., 2022). In a person with diabetes, microbleeds suggest a barrier that is already open.
• Gum numbers, not reassurance. A national survey followed people for as long as 26 years. Gum pocket depth tracked Alzheimer’s cases and deaths in people 65 and older (Beydoun et al., 2020).
• Stool form before any microbiome kit. How fast your bowel moves shapes what a kit reports. And a paid leaky gut panel may not see the gut wall at all. Stool calprotectin, a measure of bowel inflammation, asks a sharper question.

How do you repair a leaky blood-brain barrier?

The levers are the ones that move a waist size and a fasting insulin: food quality, meal timing, sleep and movement. They matter for the barrier because the long cohorts tied those two numbers, not amyloid, to the leak. No trial has yet tested whether lowering waist and fasting insulin shrinks hippocampal leakage. That is evidence from mechanism, and it is the next study worth running. The case for acting does not wait on it, because the same numbers drive inflammaging, the reason a body feels like it is failing at 50, and the wider picture of metabolic inflammation.

Ask for your waist and fasting insulin at any memory visit. The spinal side of this traffic is covered in how the gut reaches the spine, and stress, inflammation and the frightened gut follows it into trauma. Every study cited here, with the figures it gives and the limits it carries, is collected in the Deep Dive for Chapter 12.

Frequently asked questions

What is a leaky brain?

Leaky brain is a popular term for a blood-brain barrier that lets more through than it should. Contrast MRI in living people shows leakage rising with age in the hippocampus first. It rises further in mild cognitive impairment. It can be measured. In large cohorts it tracks diabetes and waist size more closely than amyloid. See how the modern plate sets the brain on fire.

Can you test for a leaky blood-brain barrier?

Research centers use dynamic contrast MRI or the spinal fluid albumin ratio, and the two do not always agree. Neither is a routine screening test. The practical stand-ins are the drivers: waist size, fasting insulin, diabetes status, and microbleeds on an ordinary brain scan in someone with diabetes. Here is the metabolic audit that shows whether your body can heal.

Is there a microbiome in the brain?

Not on the best-controlled evidence. One lab used strict contamination controls. Most apparent bacterial DNA in brain tissue turned out to be lab contamination or human DNA misread as bacteria. Bacterial products and immune signals do reach the brain across a barrier that no longer closes well. So the concern is traffic, not a colony. Learn how the vagus nerve tethers the first brain to the second.

Does APOE4 make the blood-brain barrier leak?

In one study, APOE4 carriers with normal thinking already showed barrier breakdown in the hippocampus before amyloid or tau differed. Pericyte injury predicted later decline only in carriers. That makes the barrier an early target you can measure in carriers, not a late result of plaque. See how one metabolic lever applies to APOE4 carriers.

Does belly fat affect the blood-brain barrier?

In healthy older adults, high body mass index and waist-hip ratio predicted a leaking barrier twenty years later. The leak tracked diabetes and blood-vessel stress markers, not Alzheimer’s proteins. Waist and fasting insulin are the numbers to move, through food, meal timing, sleep and movement. Read about the fuel a metabolically stressed brain is missing.

Can a leaky blood-brain barrier be repaired?

The levers are the ones that move a waist size and a fasting insulin: food quality, meal timing, sleep and movement. Long cohorts tied those two numbers, not amyloid, to the leak. No trial has yet tested whether lowering them shrinks hippocampal leakage, so this rests on mechanism. The case for acting does not wait, because the same numbers drive inflammaging.

Does diabetes cause a leaky brain?

Diabetes is one of the clearest signals. The spinal fluid albumin ratio, a barrier test, followed diabetes, not amyloid or APOE genotype. In type 2 diabetes, white matter leakage was already raised before any small vessel disease showed on a routine scan. Recent blood sugar control explained none of it. A decent A1C this quarter did not protect the barrier.

Is gum health linked to brain health?

A national survey followed people for as long as 26 years. Deeper gum pockets tracked Alzheimer’s cases and deaths in people 65 and older. That is why gum numbers belong with the tests worth knowing, not filed as a dental detail. When the barrier stays open, bacterial products and immune signals from elsewhere in the body reach the brain.

Sources

1. Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., Harrington, M. G., Chui, H. C., Law, M., & Zlokovic, B. V. (2015). Blood-brain barrier breakdown in the aging human hippocampus. Neuron, 85(2), 296-302. https://doi.org/10.1016/j.neuron.2014.12.032
2. Montagne, A., Nation, D. A., Sagare, A. P., Barisano, G., Sweeney, M. D., Chakhoyan, A., Pachicano, M., Joe, E., Nelson, A. R., D’Orazio, L. M., Buennagel, D. P., Harrington, M. G., Benzinger, T. L. S., Fagan, A. M., Ringman, J. M., Schneider, L. S., Morris, J. C., Reiman, E. M., Caselli, R. J., … Zlokovic, B. V. (2020). APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature, 581(7806), 71-76. https://doi.org/10.1038/s41586-020-2247-3
3. Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., Benzinger, T. L. S., Fagan, A. M., Ringman, J. M., Schneider, L. S., Morris, J. C., Chui, H. C., Law, M., Toga, A. W., & Zlokovic, B. V. (2019). Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nature Medicine, 25(2), 270-276. https://doi.org/10.1038/s41591-018-0297-y
4. Janelidze, S., Hertze, J., Nägga, K., Nilsson, K., Nilsson, C., Wennström, M., van Westen, D., Blennow, K., Zetterberg, H., & Hansson, O. (2017). Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype. Neurobiology of Aging, 51, 104-112. https://doi.org/10.1016/j.neurobiolaging.2016.11.017
5. Skillbäck, T., Delsing, L., Synnergren, J., Mattsson, N., Janelidze, S., Nägga, K., Kilander, L., Hicks, R., Wimo, A., Winblad, B., Hansson, O., Blennow, K., Eriksdotter, M., & Zetterberg, H. (2017). CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients. Neurobiology of Aging, 59, 1-9. https://doi.org/10.1016/j.neurobiolaging.2017.06.028
6. Chen, Y. C., Lu, B. Z., Shu, Y. C., & Sun, Y. T. (2022). Spatiotemporal dynamics of cerebral vascular permeability in type 2 diabetes-related cerebral microangiopathy. Frontiers in Endocrinology, 12, 805637. https://doi.org/10.3389/fendo.2021.805637
7. Rajani, R. M., Ratelade, J., Domenga-Denier, V., Hase, Y., Kalimo, H., Kalaria, R. N., & Joutel, A. (2019). Blood brain barrier leakage is not a consistent feature of white matter lesions in CADASIL. Acta Neuropathologica Communications, 7(1), 187. https://doi.org/10.1186/s40478-019-0844-x
8. Bedarf, J. R., Beraza, N., Khazneh, H., Ozkurt, E., Baker, D., Borger, V., Wullner, U., & Hildebrand, F. (2021). Much ado about nothing? Off-target amplification can lead to false-positive bacterial brain microbiome detection in healthy and Parkinson’s disease individuals. Microbiome, 9(1), 75. https://doi.org/10.1186/s40168-021-01012-1
9. Tan, C. C. S., Ko, K. K. K., Chen, H., Liu, J., Loh, M., Chia, M., & Nagarajan, N. (2023). No evidence for a common blood microbiome based on a population study of 9,770 healthy humans. Nature Microbiology, 8(5), 973-985. https://doi.org/10.1038/s41564-023-01350-w
10. Beydoun, M. A., Beydoun, H. A., Hossain, S., El-Hajj, Z. W., Weiss, J., & Zonderman, A. B. (2020). Clinical and bacterial markers of periodontitis and their association with incident all-cause and Alzheimer’s disease dementia in a large national survey. Journal of Alzheimer’s Disease, 75(1), 157-172. https://doi.org/10.3233/JAD-200064

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 12 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.